Identification of ELF3 as an early transcriptional regulator of human urothelium

Developmental Biology

Volumn 386, Issue 2, 2014, Pages 321-330

  Böck, Matthias ^a   Hinley, Jennifer ^b   Schmitt, Constanze ^a   Wahlicht, Tom ^b   Kramer, Stefan ^c   Southgate, Jennifer ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF YORK   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Differentiation; ELF3; Gene expression; Microarray analysis; Normal Human Urothelium; PPAR ; Time series

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 3ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF3; TRANSCRIPTION FACTOR GRHL3; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC PROCEDURES; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TIME SERIES ANALYSIS; TISSUE DIFFERENTIATION; TRANSCRIPTION REGULATION; URETER; UROPLAKIN 3A GENE; UROTHELIUM;

EUKARYOTA;

DIFFERENTIATION; ELF3; GENE EXPRESSION; MICROARRAY ANALYSIS; NORMAL HUMAN UROTHELIUM; PPARΓ; TIME SERIES;

CELL DIFFERENTIATION; DNA PRIMERS; DNA-BINDING PROTEINS; ELECTRIC IMPEDANCE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TIME FACTORS; TRANSCRIPTION FACTORS; UROTHELIUM;

EID: 84892878110     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2013.12.028     Document Type: Article

References (35)

1. Andreoli J.M., Jang S.I., Chung E., Coticchia C.M., Steinert P.M., Markova N.G. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucl. Acids Res. 1997, 25:4287-4295.
2. Bell S.M., Zhang L., Mendell A., Xu Y., Haitchi H.M., Lessard J.L., Whitsett J.A. Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. Dev. Biol. 2011, 358:79-90.
3. Boglev Y., Wilanowski T., Caddy J., Parekh V., Auden A., Darido C., Hislop N.R., Cangkrama M., Ting S.B., Jane S.M. The unique and cooperative roles of the grainy head-like transcription factors in epidermal development reflect unexpected target gene specificity. Dev. Biol. 2011, 349:512-522.
4. Conesa A., Nueda M.J., Ferrer A., Talon M. maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics 2006, 22:1096-1102.
5. Cross W.R., Eardley I., Leese H.J., Southgate J. A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function. Am. J. Physiol. Renal Physiol. 2005, 289:F459-468.
6. Fellows G.J., Marshall D.H. The permeability of human bladder epithelium to water and sodium. Invest. Urol. 1972, 9:339-344.
7. Fleming J.M., Shabir S., Varley C.L., Kirkwood L.A., White A., Holder J., Trejdosiewicz L.K., Southgate J. Differentiation-associated reprogramming of the transforming growth factor beta receptor pathway establishes the circuitry for epithelial autocrine/paracrine repair. PLoS One 2012, 7:e51404.
8. Flentjar N., Chu P.Y., Ng A.Y., Johnstone C.N., Heath J.K., Ernst M., Hertzog P.J., Pritchard M.A. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology 2007, 132:1410-1419.
9. Garthwaite M.A., Thomas D.F., Subramaniam R., Stahlschmidt J., Eardley I., Southgate J. Urothelial differentiation in vesicoureteric reflux and other urological disorders of childhood: a comparative study. Eur. Urol. 2006, 49(154-159):159-160.
10. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
11. Giltay J.C., van de Meerakker J., van Amstel H.K., de Jong T.P. No pathogenic mutations in the uroplakin III gene of 25 patients with primary vesicoureteral reflux. J. Urol. 2004, 171:931-932.
12. Hicks R.M. The fine structure of the transitional epithelium of rat ureter. J. Cell. Biol. 1965, 26:25-48.
13. Hu P., Meyers S., Liang F.X., Deng F.M., Kachar B., Zeidel M.L., Sun T.T. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am. J. Physiol. Renal Physiol. 2002, 283:F1200-1207.
14. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
15. Jenkins D., Bitner-Glindzicz M., Malcolm S., Hu C.C., Allison J., Winyard P.J., Gullett A.M., Thomas D.F., Belk R.A., Feather S.A., Sun T.T., Woolf A.S. De novo Uroplakin IIIa heterozygous mutations cause human renal adysplasia leading to severe kidney failure. J. Am. Soc. Nephrol. 2005, 16:2141-2149.
16. Jiang S., Gitlin J., Deng F.M., Liang F.X., Lee A., Atala A., Bauer S.B., Ehrlich G.D., Feather S.A., Goldberg J.D., Goodship J.A., Goodship T.H., Hermanns M., Hu F.Z., Jones K.E., Malcolm S., Mendelsohn C., Preston R.A., Retik A.B., Schneck F.X., Wright V., Ye X.Y., Woolf A.S., Wu X.R., Ostrer H., Shapiro E., Yu J., Sun T.T. Lack of major involvement of human uroplakin genes in vesicoureteral reflux: implications for disease heterogeneity. Kidney Int. 2004, 66:10-19.
17. Kauffmann A., Gentleman R., Huber W. arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 2009, 25:415-416.
18. Kelly H., Ennis S., Yoneda A., Bermingham C., Shields D.C., Molony C., Green A.J., Puri P., Barton D.E. Uroplakin III is not a major candidate gene for primary vesicoureteral reflux. Eur. J. Hum. Genet. 2005, 13:500-502.
19. Lavelle J., Meyers S., Ramage R., Bastacky S., Doty D., Apodaca G., Zeidel M.L. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am. J. Physiol. Renal Physiol. 2002, 283:F242-253.
20. Lewis S.A. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am. J. Physiol. Renal Physiol. 2000, 278:F867-874.
21. Mysorekar I.U., Mulvey M.A., Hultgren S.J., Gordon J.I. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J. Biol. Chem. 2002, 277:7412-7419.
22. Ng A.Y., Waring P., Ristevski S., Wang C., Wilson T., Pritchard M., Hertzog P., Kola I. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. Gastroenterology 2002, 122:1455-1466.
23. Oettgen P., Alani R.M., Barcinski M.A., Brown L., Akbarali Y., Boltax J., Kunsch C., Munger K., Libermann T.A. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol. Cell. Biol. 1997, 17:4419-4433.
24. Rubenwolf P., Southgate J. Permeability of differentiated human urothelium in vitro. Methods Mol. Biol. 2011, 763:207-222.
25. Schaefer U., Schmeier S., Bajic V.B. TcoF-DB: dragon database for human transcription co-factors and transcription factor interacting proteins. Nucl. Acids Res. 2011, 39:D106-110.
26. Southgate J., Hutton K.A., Thomas D.F., Trejdosiewicz L.K. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest. 1994, 71:583-594.
27. Southgate J., Masters J.R., Trejdosiewicz L.K. Culture of human urothelium. Culture of Epithelial Cells 2002, 381-400. J Wiley and Sons, Inc., New York. (2nd Ed.). R.I. Freshney, M.G. Freshney (Eds.).
28. Vaquerizas J.M., Kummerfeld S.K., Teichmann S.A., Luscombe N.M. A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 2009, 10:252-263.
29. Varley C.L., Bacon E.J., Holder J.C., Southgate J. FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation. Cell Death Differ. 2009, 16:103-114.
30. Varley C.L., Garthwaite M.A., Cross W., Hinley J., Trejdosiewicz L.K., Southgate J. PPARgamma-regulated tight junction development during human urothelial cytodifferentiation. J. Cell Physiol. 2006, 208:407-417.
31. Varley C.L., Stahlschmidt J., Lee W.C., Holder J., Diggle C., Selby P.J., Trejdosiewicz L.K., Southgate J. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme. J. Cell Sci. 2004, 117:2029-2036.
32. Varley C.L., Stahlschmidt J., Smith B., Stower M., Southgate J. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells. Am. J. Pathol. 2004, 164:1789-1798.
33. Wu X.R., Kong X.P., Pellicer A., Kreibich G., Sun T.T. Uroplakins in urothelial biology, function, and disease. Kidney Int. 2009, 75:1153-1165.
34. Yu Z., Mannik J., Soto A., Lin K.K., Andersen B. The epidermal differentiation-associated grainyhead gene Get1/Grhl3 also regulates urothelial differentiation. EMBO J. 2009, 28:1890-1903.
35. Zoppoli P., Morganella S., Ceccarelli M. TimeDelay-ARACNE: Reverse engineering of gene networks from time-course data by an information theoretic approach. BMC Bioinf. 2010, 11:154.